EVN AG:発電所・企業SWOT分析

◆英語タイトル:EVN AG - Power Plants and SWOT Analysis, 2017 Update
◆商品コード:DATA8014444
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月24日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:発電・エネルギー
◆販売価格オプション(消費税別)
Single UserUSD1,000 ⇒換算¥148,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD2,000 ⇒換算¥296,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD3,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

EVN AG – Power Plants and SWOT Analysis, 2017 Update
Summary

The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.

Scope

- Major Power Plants (assets) – summarized and detailed information about the power plants (assets).
- Operational Metrics (capacity, generation, revenue, sales, number of consumers).
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands
- Key employees – A list of the key executives and personnel heading key departments/functions.
- Executive biographies – A brief summary of the executives’ employment history.
- Financial deals – Coverage of key financial deals from 2006 onwards, depending upon information availability
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

* Note: Some sections may be missing if data is unavailable for the company.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
Company Snapshot 4
Key Information 4
Company Overview 4
SWOT Snapshot 4
Operational Metrics 5
EVN AG, Operational Metrics, By Capacity 5
EVN AG, Operational Metrics, By Generation 5
EVN AG, Operational Metrics, By Distribution 5
EVN AG, Operational Metrics, By Customers 5
EVN AG, Wind Farms 6
EVN AG, Wind Farms, Austria 6
EVN AG, Solar PV Parks 12
EVN AG, Solar PV Parks, Bulgaria 12
EVN AG, Hydro Power Plants 13
EVN AG, Hydro Power Plants, Bulgaria 13
EVN AG, Biopower Plants 14
EVN AG, Biopower Plants, Austria 14
EVN AG, Thermal Power Plants 15
EVN AG, Thermal Power Plants, Austria 15
Business Description 16
Business Overview 16
Major Products and Services 17
History 18
SWOT Analysis 21
Overview 21
EVN AG Strengths 21
Debt Reduction 21
Integrated Business Operations 21
Focused Investments 21
EVN AG Weaknesses 22
High Operational Costs: Energy Supply 22
EVN AG Opportunities 22
Favorable Renewable Policies: European Union 22
Increase in Electricity Consumption: Austria 22
Increase in Demand for Electricity: Bulgaria 22
EVN AG Threats 22
Environmental Laws and Regulations 22
Network Safety Issues 23
Operational Issues 23
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 24
Financial Ratios – Interim Ratios 26
Key Employees 27
Company Statement 28
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 31
Report Scope 31
GlobalData Coverage 31
Benchmarking 31
GlobalData’s Methodology 31
Secondary Research 31
Primary Research 32
Contact Us 32
Disclaimer 32

List of Tables
EVN AG, Key Facts 4
EVN AG, Operational Metrics, Capacity 5
EVN AG, Operational Metrics, Generation 5
EVN AG, Operational Metrics, Distribution 5
EVN AG, Operational Metrics, Customers 5
EVN AG, Wind Farms, Austria 6
EVN AG, Solar PV Parks, Bulgaria 12
EVN AG, Hydro Power Plants, Bulgaria 13
EVN AG, Biopower Plants, Austria 14
EVN AG, Thermal Power Plants, Austria 15
Major Products and Services 17
EVN AG, SWOT Analysis 21
EVN AG, Ratios based on current share price 24
EVN AG, Annual Ratios 24
EVN AG, Interim Ratios 26
EVN AG, Key Employees 27
EVN AG, Subsidiaries 29

★海外企業調査レポート[EVN AG:発電所・企業SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Veolia Environnement SA (VIE):電力:M&Aディール及び事業提携情報
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • IntraPace Inc:医療機器:M&Aディール及び事業提携情報
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company offers abiliti systems that contain sensors intended to track consumption events and physical activity to direct when therapy is delivered and to monitor a patient's progress toward wei …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析
    AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Par Pacific Holdings, Inc. (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings, Inc. (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cascadian Therapeutics Inc (CASC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …
  • RentPath, LLC:企業の戦略・SWOT・財務情報
    RentPath, LLC - Strategy, SWOT and Corporate Finance Report Summary RentPath, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bankinter Banca Privada:企業の戦略・SWOT・財務分析
    Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report Summary Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Helius Medical Technologies Inc (HSDT):企業の財務・戦略的SWOT分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • DreamWorks Animation LLC:企業の戦略的SWOT分析
    DreamWorks Animation LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Kotak Wealth Management:企業の戦略・SWOT・財務分析
    Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Timberwest Forest Corporation:企業の戦略・SWOT・財務分析
    Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Welltower Inc:企業の戦略・SWOT・財務分析
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Orphazyme AS (ORPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Orphazyme A/S (Orphazyme) formerly Orphazyme ApS, is a biopharmaceutical company that develops heat shock protein based therapies for the treatment of orphan protein-misfolding diseases. Its lead product drug candidate arimoclomol is under clinical development for treating neuromuscular dise …
  • Mitsui E&S Holdings Co., Ltd. (7003):電力:M&Aディール及び事業提携情報
    Summary Mitsui E&S Holdings Co., Ltd. (Mitsui E&S) is a shipbuilding and engineering product manufacturing company. It has diversified business operations comprising environment recycling, construction of social infrastructure, advanced machinery systems, IT-related activities, ships and oceans, pla …
  • Titanium Metals Corporation:企業の戦略・SWOT・財務情報
    Titanium Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Titanium Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • United Utilities Group Plc (UU):企業の財務・戦略的SWOT分析
    United Utilities Group Plc (UU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mediolanum farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a developer and supplier of pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas, which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolics. It …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆